How the Government Will Pay Companies to Develop Biodefense Products and Win Lucrative PRVs - 15 August 2017
How the Government Will Pay Companies to Develop Biodefense Products and Win Lucrative PRVs
For those of you who care to be constructive with your posts, SIGA posted a confirmation today of a prior Bullish Harami Cross and activated a buy recommendation. If it can maintain its position above the long-term downtrend line, it should readily move back to its prior annual high of about $3.75, and then meet some resistance at $4.50, prior to a move to its intermediate price objective of about $6.50. Remember, technical analysis is little more than measuring patterns that have been developed out of observations of past performance, and applying them when a stock exhibits similar characteristics currently.
However, fundamental analysis can show that other activities (other than the supply and demand for a stock) can initiate and accelerate any such moves. There are several positive factors that are expected to come to fruition over the year to two-year horizon which can come about sooner. This observation is based upon the fact that, in the past, SIGA's management has not been in the habit of pumping its stock, or relating overly optimistic projections.
Bioterrorism threats require common global experimentation oversight, expert says - Homeland Preparedness News
Without an internationally standardized approval process to guide countries in conducting public health-related experiments, resurrecting an eradicated disease in the lab increases the risk it could be used as an agent of bioterrorism, says Dr. Tom I
Big hiccup at Chimerix. Clearly this creates a big delay. CEO said
"We continue our development of brinci for smallpox in collaboration with BARDA. On Friday, we received correspondence from the FDA that we will need to conduct a second rabbitpox study. We have to get clarity from the FDA in the near future. We believe the following outcomes are possible, one, we may need to conduct a second rabbitpox study; two, we may be able to rely on the one pivotal rabbitpox study we have already conducted and filed; or a third alternative outcome. Once we have agreement on the development plan with BARDA and the FDA, we will certainly share those with you."
1. PN744 — 115th Congress (2017-2018) — Robert P. Kadlec — Department of Health and Human Services Robert P. Kadlec, of New York, to be Medical Director in the Regular Corps of the Public Health Service, subject to qualifications therefor as provided by law and regulations, and to be Assistant Secretary for Preparedness and Response, Department of Health and Human Services, vice Nicole Lurie. Date Received from President: 07/11/2017 Committee: Health, Education, Labor, and Pensions Latest Action: 08/03/2017 - Confirmed by the Senate by Voice Vote. (All Actions)
LOL! Now I know why Sally has suddenly gone so quite!! NICE CALL ON BLCM! How many idiots bought that stock on her/a random person's recommendation? AGAIN, you NEVER EVER listen to someone on a message board! Well done Sally, you're a classic schmuck!
And there it is folks, THE TWO DOLLAR BREACH!! As promised. It happened. Now are you going to be angry with me for calling it, or are you going to be angry with management for not caring? The choice is yours to make if you continue to blindly invest in this company while they give themselves raises and stock shares, all at your cost. Where are nicehedges and Sally to calm everyone down and just tell them it's in the greater plan of SIGA management to allow this? The good news is that this is officially the 423rd buying opportunity for this stock! Buy away! More like, buy into the B-S!
Kadlec in an interview a few years ago:
The reality is that we need two smallpox antiviral drugs," says Robert Kadlec, a former Senate staff member who helped to write the 2006 legislation that created BARDA.
Senate HELP Committee likely to approve Kadlec as nominee for preparedness and response at HHS - Homeland Preparedness News
Dr. Robert Kadlec of Alexandria, Virginia, who was nominated last month by President Donald Trump to be assistant secretary for preparedness and response at the U.S. Department of Health and Human Services (HHS), is expected to be approved on Wednesd
White House working on pandemic, biosecurity strategy - Homeland Preparedness News
Responding to what he calls a need for a bio-defense strategy, the Trump Administration’s homeland security advisor, Thomas Bossert, has promised the White House is developing the first comprehensive plan for disease and biological attacks. “At this
Uh-oh!! Looks like my prediction is so close to coming true. And you folks just want to keep sticking your heads in the sand and get angry at me instead of the management team that doesn't give a HOOT about the stock price!!
Been away on vacation....did I miss anything? any big news? Share price pop? Management do anything? Nah....it appears all is status quo and we're more likely to hit the 2s in the short term than the 4s.....and then some fools will claim they're buying more in this, the 423rd buying opportunity.
Folks, here's the plain and simple problem, as I see it, outside of the management issue.
WHAT exactly is their business model? What do they produce that is going to be a consistent and replenished source of business. Yeah, the government could/will buy more smallpox drugs. But outside of that or a major smallpox disaster, what does this company have? Their only hope is really that their general antiviral 669 is a success, then they'd be a heck of a rich company. But that is a long long way off and, even if it is remotely possible, this management team will find a way to blow it. Most businesses fail not because of the product, but because the company doesn't have the right people in place to take the company forward. This company has scientists that think they're businessmen. We've been waiting OVER TEN YEARS for something significant to happen here and it hasn't. I'd love for a SIGA cheerleader to give me an honest response to these thought out questions. But I'll probably just get 4 thumbs down (two from the same person) and an insult from Sally. And then you folks wonder why you can't invest in a good stock.
" Bossert, however, said that the administration plans to give “full-throated support” to the Global Health Security Agenda, a partnership of more than 50 nations and international organizations that works to build countries’ capacities to prevent and fight infectious diseases." "
" “That’s (horsepox) not going to kill any of us, but that suggests that somebody might now in the future possess the ability to produce synthetic small pox without a live virus and that scares me to death,” he said. "
White House developing comprehensive biosecurity strategy: official
The Trump administration is developing the first comprehensive strategy to defend the United States against disease pandemics and biological attacks by terrorists, the top White House homeland security official said on Thursday.
As the company continues to look for business opportunities to help with its expansion plan, Havey said more deals could come soon.
“We’re still very acquisitive,” he said. “We’re definitely not done. We have active deals in our pipeline. That’s not going to stop or slow down.”
Why a biodefense firm is going on a spending spree
Emergent wants to step up its international business.
Really One Stink'in share ONE as in UnO well there is a new one even for Siga. So any takers on my Relisting prediction time line now?????? (I say Min 1.5yrs or as much as 4yrs until they even Qualify) could see this trading for $$$$ and not being interested in leaving the OTC.....
WOW!! All of this fantastic news posted by the Queen of SIGA, nicehedges, and his jester Sally....yet the stock is down over 8%. What a stock, what a company!!! Impressive display of not giving a turd by this management team! You're all going to be rich in no time!!